Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions-Reference-Cited by-同舟云学术

Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions

Published:2006-07-06 Issue:3 Volume:1 Page:223-236
ISSN:1557-1890
Container-title:Journal of Neuroimmune Pharmacology
language:en
Short-container-title:Jrnl Neuroimmune Pharm

Author:

Persidsky Yuri,Ramirez Servio H.,Haorah James,Kanmogne Georgette D.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Immunology,Immunology and Allergy,Neuroscience (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s11481-006-9025-3.pdf

Reference172 articles.

1. Abbott NJ (2000) Inflammatory mediators and modulation of blood–brain barrier permeability. Cell Mol Neurobiol 20:131–147

2. Abbott NJ (2002) Astrocyte–endothelial interactions and blood–brain barrier permeability. J Anat 200:629–638

3. Abbott NJ (2005) Dynamics of CNS barriers: evolution, differentiation, and modulation. Cell Mol Neurobiol 25:5–23

4. Abbott NJ, Ronnback L, Hansson E (2006) Astrocyte–endothelial interactions at the blood–brain barrier. Nat Rev Neurosci 7:41–53

5. Adamson P, Etienne S, Couraud PO, Calder V, Greenwood J (1999) Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway. J Immunol 162:2964–2973

Cited by 735 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving glioma drug delivery: A multifaceted approach for glioma drug development;Pharmacological Research;2024-10

2. α7nACh receptor, a promising target to reduce BBB damage by regulating inflammation and autophagy after ischemic stroke;Biomedicine & Pharmacotherapy;2024-10

3. Neuroinflammation and Brain Health Risks in Veterans Exposed to Burn Pit Toxins;International Journal of Molecular Sciences;2024-09-10

4. Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer;Pharmaceutics;2024-09-07

5. Utilizing Multifaceted Approaches to Target Drug Delivery in the Brain: From Nanoparticles to Biological Therapies;Cureus;2024-09-01